16 related articles for article (PubMed ID: 18540169)
1. Effect of adriblastin on viability, cell cycle and apoptosis in B16 and cloudman s91 mouse melanoma cells in vitro.
Olszewska-Słonina D; Drewa T; Czajkowski R; Olszewski K
Acta Pol Pharm; 2004; 61(6):439-46. PubMed ID: 15794336
[TBL] [Abstract][Full Text] [Related]
2. B16 and cloudman S91 mouse melanoma cells susceptibility to apoptosis after dacarbazine treatment.
Olszewska-Słonina DM; Styczyńisk J; Drewa TA; Olszewski KJ; Czajkowski R
Acta Pol Pharm; 2005; 62(6):473-83. PubMed ID: 16583988
[TBL] [Abstract][Full Text] [Related]
3. B16 and CLS91 mouse melanoma cells susceptibility to apoptosis after vincristin treatment in vitro.
Olszewska-Słonina D; Drewa T; Styczyński J; Olszewski K; Musiałkiewicz D
Acta Pol Pharm; 2004; 61(2):113-21. PubMed ID: 15493293
[TBL] [Abstract][Full Text] [Related]
4. Influence of a novel platinum compound--cis-dichloro (dimethylsulphoxide) (1-beta-D-rybofuranosyl-1,2,4-triazolo-3-arboxyamide) platinum (II)--"Pt-rib-1"--on cell cycle and apoptosis in ClS91 and B16 mouse melanoma in vitro.
Drewa T; Olszewska-Słonina D; Woźniak A; Styczyński J; Drewa G; Szłyk E; Lakomska I; Kobe J; Czajkowski R
Acta Pol Pharm; 2004; 61(1):39-44. PubMed ID: 15259856
[TBL] [Abstract][Full Text] [Related]
5. Comparison of viability of B16 and Cl S91 cells in three cytotoxicity tests: cells counting, MTT and flow cytometry after cytostatic drug treatment.
Olszewska-Słonina D; Drewa T; Musiałkiewicz D; Olszewski K
Acta Pol Pharm; 2004; 61(1):31-7. PubMed ID: 15259855
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle, melanin contents and apoptosis processes in B16 and Cloudman S91 mouse melanoma cells after exposure to cytostatic drugs.
Olszewska-Słonina DM; Styczyński J; Czajkowski R; Drewa TA; Musiałkiewicz D
Acta Pol Pharm; 2007; 64(5):469-78. PubMed ID: 18540169
[TBL] [Abstract][Full Text] [Related]
7. Methodology for evaluation of melanin content and production of pigment cells in vitro.
Hu DN
Photochem Photobiol; 2008; 84(3):645-9. PubMed ID: 18435617
[TBL] [Abstract][Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
